to give some scientific light on what we were saying before about the
correlation betwen degenerative diseases and infctuous diseases, read this
article.

http://www.the-scientist.com/yr2000/feb/halim_p8_000221.html

some extracts from The Scientist 14[4]:8, Feb. 21, 2000

<The positive side of salmonella
When the public hears about Salmonella, it is usually in a warning about
food poisoning, but a group of researchers in New Haven, Conn., is using the
bacteria to target cancer. It turns out that Salmonella preferentially
colonize and multiply within a tumor, thereby inhibiting growth. Vion
Pharmaceuticals is taking advantage of this trait by genetically altering
Salmonella typhimurium to reduce the serious toxicities associated with
wild-type infection and create a novel cancer treatment.>
...

<The association between bacterial infection and tumor regression has
existed since the turn of the century. William B. Coley, attending bone
surgeon at Memorial Hospital, now Memorial Sloan-Kettering Cancer Center,
noticed that patients who developed severe infections after surgery for
sarcoma fared much better than those who did not develop postoperative
infections. Based on these observations, Coley purified a component of the
bacterial cell wall for the treatment of cancer.1 "Coley's toxin" was
eventually marketed by Parke-Davis until the 1950s.>

...

<In the 1940s, researchers found another relationship between bacteria and
cancer: Clostridia, strict anaerobic bacteria that cause gangrene and
botulism, could infect tumors. Clostridia seemed to like the necrotic and
anaerobic environment in large tumors. Nonpathogenic strains showed some
success in mice, but only on larger tumors. Further research showed that
Clostridia did not work as an antitumor agent in humans. >

...
<The bacteria disseminate throughout the body, but they cannot cross the
blood-brain barrier. In a tumor they reach a concentration that is 1,000
times greater than in the liver and spleen, the next-highest concentration.
"Compared to other targeting mechanisms such as monoclonal antibodies, the
specificity is remarkable," comments Bermudes>



i did appreciate in this article the scientific obsession of singularising
causes  of an effect and making a potential economic use of it .

i also did appreciated the insistance of the writer to make sure that the
reader got the idea that this kind of salmonella is safe . ( that is sort of
necessary after having scared away people with the opposite idea  for so
long)
jean-claude